Literature DB >> 18059065

The assessment of absorption of periplocin in situ via intestinal perfusion of rats by HPLC.

Yue-Sheng Xie1, Xiao-Liang Ren, Gui-Xiang Pan, Xiu-Mei Gao, Chang-Xiao Liu.   

Abstract

Periplocin is an important compound of Cortex Periplocae, which shows poor absorption when administered orally. The effective intestinal permeability of periplocin was investigated using single-pass intestinal perfusion technique in male Wistar rats. SPIP was performed in rat jejunum. The samples of perfusate were collected at the designated time points after rat intestinal perfusion and analyzed by HPLC. The specificity of this method was demonstrated by the absence of interference of the drug peak with the intestinal sac artifacts and the components of the KRB solution. Recovery studies, as well as the intra-day and inter-day variations, were within statistical limits. This technique was applied to the study of the intestinal absorption of periplocin. The determined fraction absorbed (F(a)) of periplocin was 0.151 +/- 0.072 (n = 6) at a concentration of 6 microg/mL; the absorption rate constant (K(a)) was 0.0102 +/- 0.0039/min and the effective permeability coefficient (P(eff)) was 0.0021 +/- 0.0012 cm/min. These data suggest that periplocin has high permeability and might be absorbed in rat intestine. (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18059065     DOI: 10.1002/bmc.914

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  2 in total

1.  Gene expression profiling of the proliferative effect of periplocin on mouse cardiac microvascular endothelial cells.

Authors:  Xiao-ying Wang; Xiu-mei Gao; Hong Liu; Han Zhang; Yang Liu; Min Jiang; Li-min Hu; Bo-li Zhang
Journal:  Chin J Integr Med       Date:  2010-02-04       Impact factor: 1.978

2.  The Effect of Particle Size on the Absorption of Cyclosporin A Nanosuspensions.

Authors:  Wenjun Sun; Jing Gao; Ranran Fan; Ting Zhang; Yang Tian; Zengming Wang; Hui Zhang; Aiping Zheng
Journal:  Int J Nanomedicine       Date:  2022-04-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.